share_log

Earnings Call Summary | Quipt Home Medical(QIPT.US) Q1 2024 Earnings Conference

Earnings Call Summary | Quipt Home Medical(QIPT.US) Q1 2024 Earnings Conference

業績電話會議摘要 | Qipt Home Medical (QIPT.US) 2024 年第一季度業績發佈會
富途資訊 ·  02/16 09:01  · 電話會議

The following is a summary of the Quipt Home Medical Corp. (QIPT) Q1 2024 Earnings Call Transcript:

以下是Quipt Home Medical Corp.(QIPT)2024年第一季度業績電話會議記錄的摘要:

Financial Performance:

財務業績:

  • Quipt Home Medical reported Q1 2024 record revenue of $65.4 million, a 60% increase year-over-year.

  • The adjusted EBITDA was $15.3 million, marking a 71% rise from the same period last year.

  • The company's recurring revenue now represents 83% of total revenue.

  • Cash flow from continuing operations significantly increased by 143% to $11.7 million.

  • Quipt has a cash balance of $18.3 million and a total credit ability of $41 million.

  • Quipt Home Medical報告稱,2024年第一季度收入創紀錄的6,540萬美元,同比增長60%。

  • 調整後的息稅折舊攤銷前利潤爲1,530萬美元,比去年同期增長71%。

  • 該公司的經常性收入現在佔總收入的83%。

  • 來自持續經營業務的現金流大幅增長了143%,達到1170萬美元。

  • Quipt的現金餘額爲1,830萬美元,總信貸能力爲4,100萬美元。

Business Progress:

業務進展:

  • Quipt Home Medical serves over 155,434 unique patients, a 56% increase from last year.

  • Completed 215,370 unique setups and deliveries, including 123,190 respiratory resupply setups deliveries, marking respective increases of 47% and 77%.

  • The company expects a steady organic growth of 8% to 10% for fiscal 2024 driven by their growing sales team, product cross-selling, and market expansion.

  • The company aims to use technology to drive automation and enhance operational efficiency.

  • Plans to capitalize on the increasing need for in-home medical equipment and services due to an aging population and a rise in chronic illnesses.

  • Continuation of strategic acquisitions to expand both their payer base and geographic reach.

  • Focusing on their sleep segment in response to an increasing prevalence of obstructive sleep apnea for potential future market expansion.

  • Quipt Home Medical爲超過155,434名獨特的患者提供服務,比去年增長了56%。

  • 完成了215,370套獨特的設置和交付,包括123,190套呼吸補給裝置的交付,分別增長了47%和77%。

  • 該公司預計,在其不斷壯大的銷售團隊、產品交叉銷售和市場擴張的推動下,2024財年將實現8%至10%的穩定有機增長。

  • 該公司的目標是使用技術來推動自動化並提高運營效率。

  • 計劃利用由於人口老齡化和慢性病增加而對家用醫療設備和服務不斷增長的需求。

  • 繼續進行戰略收購,以擴大其付款人基礎和地域覆蓋範圍。

  • 專注於他們的睡眠細分市場,以應對阻塞性睡眠呼吸暫停患病率上升,以應對未來潛在的市場擴張。

More details: Quipt Home Medical IR

更多詳情: Quipt 家庭醫療紅外

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

提示:欲了解更多詳情,請訪問投資者關係網站。本文僅供投資者參考,不構成任何投資建議。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論